# Exploratory Study on the S-1 + Paclitaxel Chemotherapy for Unresectable Gastric Cancer

> **NCT01756183** · PHASE2 · UNKNOWN · sponsor: **Zhejiang Cancer Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Surgically-Created Resection Cavity
- Drug Safety

## Interventions

- **DRUG:** S-1 + Paclitaxel Chemotherapy

## Key facts

- **NCT ID:** NCT01756183
- **Lead sponsor:** Zhejiang Cancer Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-09
- **Primary completion:** 2013-09
- **Final completion:** 2016-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2012-12-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01756183

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01756183, "Exploratory Study on the S-1 + Paclitaxel Chemotherapy for Unresectable Gastric Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01756183. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*